Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shopify
SHOP
|
+$1.44B |
| 2 |
PepsiCo
PEP
|
+$959M |
| 3 |
Ferrari
RACE
|
+$611M |
| 4 |
Mercado Libre
MELI
|
+$563M |
| 5 |
Netflix
NFLX
|
+$532M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.34B |
| 2 |
Microsoft
MSFT
|
+$1.2B |
| 3 |
Constellation Brands
STZ
|
+$1.04B |
| 4 |
EOG Resources
EOG
|
+$865M |
| 5 |
Amgen
AMGN
|
+$814M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Healthcare | 14.72% |
| 3 | Communication Services | 14.7% |
| 4 | Consumer Discretionary | 13.41% |
| 5 | Financials | 9.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Nutrien
NTR
$32.1B
| $190M | 0.04% |
3,131,858
-2,329,783
| -43% | -$138M |
|
252
PAR Technology
PAR
$741M
| $185M | 0.04% |
2,648,851
+679,291
| +34% | +$48.1M |
|
|
IBTX
253
DELISTED
Independent Bank Group, Inc.
IBTX
| $184M | 0.04% |
2,484,346
+634,700
| +34% | +$48.1M |
|
|
XM
254
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $180M | 0.04% |
4,703,223
+1,536,614
| +49% | +$53.9M |
|
|
AMTI
255
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $180M | 0.04% |
3,930,356
+1,151,525
| +41% | +$54.5M |
|
256
Merck
MRK
$328B
| $180M | 0.04% |
2,310,259
-3,300,114
| -59% | -$245M |
|
257
Haemonetics
HAE
$4.16B
| $179M | 0.04% |
2,679,336
-3,538,162
| -57% | -$250M |
|
|
NVRO
258
DELISTED
NEVRO CORP.
NVRO
| $177M | 0.04% |
1,066,185
+156,379
| +17% | +$24.4M |
|
|
OLO
259
DELISTED
Olo Inc
OLO
| $175M | 0.04% |
4,691,500
+1,271,500
| +37% | +$40.4M |
|
260
New York Times
NYT
$10.3B
| $173M | 0.04% |
3,971,995
-121,492
| -3% | -$5.41M |
|
261
Health Catalyst
HCAT
$135M
| $171M | 0.04% |
3,089,217
+94,917
| +3% | +$5.06M |
|
262
Asana
ASAN
$2.07B
| $169M | 0.04% |
2,724,132
+223,489
| +9% | +$8.62M |
|
|
RDS.A
263
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $163M | 0.04% |
4,023,686
-483,786
| -11% | -$19.2M |
|
|
OCFT
264
DELISTED
OneConnect Financial Technology
OCFT
| $161M | 0.04% |
1,340,570
+183,573
| +16% | +$26.3M |
|
265
SouthState Bank Corp
SSB
$10.7B
| $159M | 0.04% |
1,948,078
+155,623
| +9% | +$13.2M |
|
266
Globus Medical
GMED
$11.5B
| $159M | 0.04% |
2,053,234
| – | – |
|
|
VGR
267
DELISTED
Vector Group Ltd.
VGR
| $159M | 0.04% |
15,849,401
+87,764
| +0.6% | +$874K |
|
268
Americold
COLD
$4.17B
| $153M | 0.04% |
4,037,013
-692,697
| -15% | -$26.8M |
|
269
Darden Restaurants
DRI
$25.9B
| $148M | 0.03% |
1,010,816
-831,426
| -45% | -$117M |
|
270
Rapid7
RPD
$827M
| $145M | 0.03% |
1,527,366
+854,866
| +127% | +$72M |
|
271
AppFolio
APPF
$6.97B
| $144M | 0.03% |
1,020,791
-4,664
| -0.5% | -$648K |
|
272
Allogene Therapeutics
ALLO
$714M
| $141M | 0.03% |
5,404,300
-7,259,713
| -57% | -$207M |
|
273
Johnson & Johnson
JNJ
$629B
| $136M | 0.03% |
827,380
-603,571
| -42% | -$99.9M |
|
274
Kimberly-Clark
KMB
$36.2B
| $136M | 0.03% |
1,014,891
-1,054
| -0.1% | -$141K |
|
|
AVLR
275
DELISTED
Avalara, Inc.
AVLR
| $136M | 0.03% |
838,436
-54,697
| -6% | -$7.62M |
|
Similar funds
Capital Research Global Investors's Q2 2021 Portfolio in Review
As of Q2 2021, Capital Research Global Investors held 461 positions worth $430B, up 5.1% from $409B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Capital Research Global Investors's Q2 2021 filing shows 36 new, 172 increased, 188 reduced and 25 closed positions. Its largest new stake was Ferrari: 2,928,136 shares worth $604M. The largest sale was Broadcom, an estimated $1.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Communication Services.
- Capital Research Global Investors's largest Q2 2021 buy was Ferrari: 2,928,136 shares worth $604M.
- Capital Research Global Investors added most to Shopify in Q2 2021, an estimated $1.44B increase.
- Capital Research Global Investors's biggest Q2 2021 reduction was Broadcom, cutting an estimated $1.34B.
- Capital Research Global Investors fully exited Intel in Q2 2021, selling an estimated $577M.
- Capital Research Global Investors's ten largest holdings make up 29% of its $430B portfolio in Q2 2021.
- Capital Research Global Investors opened 36 new positions and closed 25 in Q2 2021.
- Capital Research Global Investors's portfolio value rose 5.1% quarter-over-quarter to $430B.
Based on Capital Research Global Investors's 13F filing for Q2 2021, filed 16 Aug 2021.